13F Holdings
中文EN

JRSS JRSIS HEALTH CARE Corp

Services-Hospitals · OTC · SEC CIK 1597892 · Fiscal year ends 12/31

Financial factors as of 2024-09-30 (2024Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-100.5%
TTM EPS YoY-100.1%
Revenue 3-yr CAGR-52.4%
Net income 3-yr CAGR—

Margins

Gross margin9.4%
Operating margin-7.0%
Net margin-3.7%
FCF margin—
EBITDA margin-6.4%

Returns

ROE-125.7%
ROA-13.2%
ROIC (approx.)-171.2%
Asset turnover3.58x

Leverage & solvency

Liabilities / assets111.3%
Debt / equity—
Current ratio0.78x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.67x
Accruals ratio8.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20232023-12-31FY20222022-12-31FY20212021-12-31FY20202020-12-31FY20192019-12-31
Income statement
Revenue$3.46M$1.72M$44.39M$35.71M$31.46M
Cost of revenue$2.98M$1.69M———
Gross profit$483,051$26,211———
R&D expense$189,266$283,043———
SG&A expense$336,049$283,293———
Operating income-$188,598-$684,776-$103,801$5.59M$4.67M
Interest expense$56,443$64,709$1.38M$1.14M$1.11M
Pretax income-$85,613-$673,260-$103,801$5.20M$1.93M
Income tax$8,975—$1.18M$1.37M$657,699
Net income-$80,912-$575,839$3.19M$3.83M$888,061
EBITDA-$134,783-$649,873$3.21M$8.29M$6.88M
EPS (basic)-0.00-0.010.170.150.05
EPS (diluted)-0.00-0.010.170.150.05
Weighted avg. shares (diluted)77.25M61.33M18.66M18.27M16.78M
Balance sheet
Cash & equivalents$118,114$158,813$73,253$844,827$1.97M
Receivables$714,658$683,452$7.54M$4.39M$4.58M
Inventory$455,240$562,015$1.77M$1.46M$1.07M
Current assets$1.83M$1.66M$13.87M$7.88M$9.51M
PP&E, net$50,024$62,223$33.16M$31.46M$22.84M
Intangibles$257,334$303,195———
Total assets$2.14M$2.04M$75.69M$58.80M$51.63M
Current liabilities$2.28M$2.11M$17.60M$11.76M$10.92M
Short-term debt$18,713$49,709———
Long-term debt$24,950————
Total debt$43,663————
Total liabilities$2.31M$2.11M$42.59M$29.96M$28.64M
Shareholders' equity-$137,406-$58,453$33.10M$19.04M$14.82M
Net debt-$74,451————
Shares outstanding82.59M76.76M18.63M18.25M17.98M
Cash flow statement
Operating cash flow$516,724-$1.76M$8.23M$10.64M$11.85M
Capital expenditure$1,484$44,644$2.31M$8.27M$4.71M
Free cash flow$515,240-$1.81M$5.93M$2.37M$7.13M
Investing cash flow$18,885-$2.83M-$5.50M-$8.27M-$3.96M
Financing cash flow-$568,365$1.86M-$2.80M-$3.43M-$6.11M
Depreciation & amortization$53,815$34,903$3.31M$2.70M$2.21M
Stock-based compensation—$245,465———

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.